Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
Sign in with Google
bullish
VIOL
Watchlist
KOSDAQ150 Index Adhoc Rebalance Preview: Replacements for Jeisys Medical
Event-Driven
358 Views
20 Aug 2024 00:46
Archimed holds 91.35% of the shares in Jeisys Medical. With trading halted in Jeisys, the KRX could announce a replacement for the KOSDAQ150 Index. Viol looks like a possible inclusion.
What is covered in the Full Insight:
Introduction
Jeisys Medical Delisting
KOSDAQ 150 Index Ad hoc Inclusion Timeline
Replacement Candidates
Conclusion
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Loading
Trending Insights
More »
Santos (STO AU): XRG Consortium's Big Offer; Index Impact
MV Global Junior Gold Miners Index Rebalance: Stocks at Their Highs
Pop Mart (9992 HK): Beyond Blind Boxes -Jewellery Debut. Stock Up 200% YTD. Is It Still a Buy?
MV Australia Equal Weight Index Rebalance: MinRes, Pilbara Deleted as Trade Nears A$300m
Santos Ltd (STO AU): FIRB Approval For XRG's Tilt Will Be No Pushover
Top Unpaywalled Insights
More »
Loading
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Korea Value-Up Index: Estimated Passive Flows as ETF Launches Coming
20 Oct 2024
KOSDAQ150 Index Rebalance Preview: 10 Changes in December
09 Oct 2024
KOSDAQ150 Index Adhoc Rebalance: HLB Therapeutics Replaces Jeisys Medical
22 Sep 2024
KOSDAQ150 Index Adhoc Rebalance Preview: Replacements for Jeisys Medical
20 Aug 2024
KOSDAQ150 Adhoc Index Rebalance: Webzen to Replace Connectwave
12 Aug 2024
KOSDAQ150 Adhoc Index Rebalance: Eco&Dream to Replace Paradise Co
18 Jun 2024
KOSDAQ150 Index Rebalance: Short Sell Ban Definitely Helping
26 May 2024
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.53.3
x